Background Prostate cancer progresses slowly when present in low risk forms but can be
lethal when it progresses to metastatic disease. A non-invasive test that can detect …

Abstract Purpose Prostate cancer (PCa) is one of the most common cancers and one of the
leading causes of death worldwide. Thus, one major issue in PCa research is to accurately …

Simple Summary Prostate cancer is the most frequent cancer type and one of the leading
causes of death in men globally. Multiple biomarkers analyzed in urine have been proposed …

Background To reduce overdiagnosis and overtreatment, a test is urgently needed to detect
clinically significant prostate cancer (PCa). Objective To develop a multimodal model …

The purpose of this review is to highlight the role of existing and promising urinary
biomarkers for the detection and prognostication of prostate cancer (PCa). A number of …

BACKGROUND Multiplex urine‐based assay emerged outperforms single biomarker (eg,
prostate‐specific antigen, PSA) for predicting prostate cancer (CaP), whereas its combined …

Use of serum prostate-specific antigen (PSA) testing for early detection of prostate cancer
appears to reduce cancer-specific mortality. Due to the limited specificity of PSA for clinically …

Over the past several years, the management of localized prostate cancer has seen the
development of several novel biomarkers aimed at improving decision making. Although a …

Purpose: Prostate cancer aggressiveness and appropriate therapy are routinely determined
following biopsy sampling. Current clinical and pathologic parameters are insufficient for …

Background/Aim: Prostate cancer (PCa) diagnosis using patient urine samples represents a
non-invasive and more convenient method than the conventional biopsy and prostate …